Acorda Therapeutics is a biotechnology company dedicated to the development and commercialization of therapies to improve neurological function in people with spinal cord injury, multiple sclerosis and related conditions of the nervous system.

We rely on talented and motivated people who can thrive on the challenges of building a successful biotechnology enterprise. Acorda is an active member of the New York Biotechnology Association (NYBA) and we regularly participate in industry meetings and forums to help Acorda to remain competitive in its compensation and rewards programs.

We strive to create a positive work environment where all employees are appreciated for the contributions they make to the Company.